References
- PalellaFJJrDelaneyKMMoormanACDeclining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study InvestigatorsN Engl J Med1998338138538609516219
- Antiretroviral Therapy Cohort CollaborationLife expectance of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesLancet2008372963529329918657708
- HarrisonKMSongRZhangXLife expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United StatesJ Acquir Immune Defic Syndr201053112413019730109
- LimaVDHoggRSHarriganPRContinued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapyAIDS200721668569217413689
- SamjiHCesconAHoggRSClosing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaPLoS One2013812e8135524367482
- Joint United Nations Programme on HIV/AIDS (UNAIDS)Global report: UNAIDS report on the global AIDS epidemic 2013Joint United Nations Programme on HIV/AIDS (UNAIDS)2013 Available from: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdfAccessed November 16, 2015
- Centers for Disease Control and Prevention [homepage on the Internet]HIV Among Women. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention: US Department of Health and Human Services Available from: http://www.cdc.gov/hiv/group/gender/women/index.html#refa. Updated June 23, 2015Accessed November 16, 2015
- Public Health Agency of CanadaHIV and AIDS in Canada: Surveillance Report to December 31, 2013Minister of Public Works and Government Services Canada2014Public Health Agency of Canada2014 Available from: http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/2013/dec/assets/pdf/hiv-aids-surveillence-eng.pdfAccessed November 16, 2015
- CejtinHECare of the Human immunodeficiency virus-infected menopausal womanAm J Obstet Gynecol20122072879322284959
- KanapathipillaiRHickeyMGilesMHuman immunodeficiency virus and menopauseMenopause201320998399023531684
- Centers for Disease Control and Prevention [homepage on the Internet]HIV Among People Aged 50 and Over. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention: US Department of Health and Human Services Available from: http://www.cdc.gov/hiv/group/age/olderamericans/index.html. Updated May 12, 2015Accessed November 16, 2015
- American Psychological Association [homepage on the Internet]KarpiakSAdherence to antiretroviral therapy (ART) in older adults living with HIV/AIDSAmerican Psychological Association2014 Available from: http://www.apa.org/pi/aids/resources/exchange/2014/01/anti-retroviral-therapy.aspxAccessed November 16, 2015
- FantryLEZhanMTaylorGHSillAMFlawsJAAge of menopause and menopausal symptoms in HIV-infected womenAIDS Patient Care STDS2005191170371116283830
- World Health OrganizationWHO Scientific Group on Research on the Menopause in the 1990’sWHO Technical Report Series 866Geneva, Switzerland1996 Available from: http://apps.who.int/iris/bitstream/10665/41841/1/WHO_TRS_866.pdfAccessed November 16, 2015
- International Menopause Society [homepage on the Internet]Menopause Terminology. International Menopause Society Available from: http://www.imsociety.org/menopause_terminology.phpAccessed November 16, 2015
- BrambillaDJMcKinlaySMA prospective study of factors affecting age at menopauseJ Clin Epidemiol19894211103110392809660
- McKinlaySMBifanoNLMcKinlayJBSmoking and age at menopause in womenAnn Intern Med198510333503564026083
- CondeDMPinto-NetoAMCosta-PaivaLAge at menopause of HIV-infected women: a reviewGynecol Endocrinol2008242848618210331
- CalvetGAGrinsztejnBGQuintanaMSPredictors of early menopause in HIV-infected women: a prospective cohort studyAm J Obstet Gynecol20152126765.e1e1325557206
- ThomasFRenaudFBeneficeEde MeeusTGueganJFInternational variability of ages at menarche and menopause: patterns and main determinantsHum Biol200173227129011446429
- HarlowSDGassMHallJEExecutive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive agingMenopause201219438739522343510
- ShusterLTRhodesDJGostoutBSGrossardtBRRoccaWAPremature menopause or early menopause: long-term health consequencesMaturitas201065216116619733988
- FanMDMaslowBSSantoroNSchoenbaumEHIV and menopauseMenopause Int200814416316819037065
- BlumelJECastelo-BrancoCBinfaLQuality of life after the menopause: a population studyMaturitas2000341172310687878
- CondeDMPinto-NetoAMSantos-SaDCosta-PaivaLMartinezEZFactors associated with quality of life in a cohort of postmenopausal womenGynecol Endocrinol200622844144617012106
- UtianWHPsychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive reviewHealth Qual Life Outcomes200534716083502
- Lui-FilhoJFValadaresALRGomesDCAmaralEPinto-NetoAMCosta-PaivaLMenopausal symptoms and associated factors in HIV-positive womenMaturitas201376217217823993758
- KojicEMWangCCCu-UvinSHIV and menopause: a reviewJ Womens Health (Larchmt)200716101402141118062755
- ZapantisGSantoroNThe menopausal transition: characteristics and managementBest Pract Res Clin Endocrinol Metab2003171335212763511
- ZablotskyDKennedyMRisk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practicesJ Acquir Immune Defic Syndr200333Suppl 2S122S13012853861
- AlthoffKNGeboKAGangeSJCD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?AIDS Res Ther201074521159161
- SamuelMIWelchJTenant-FlowersMPoultonMCampbellLTaylorCCare of HIV-positive women aged 50 and over – can we do better?Int J STD AIDS201425430330524047886
- DuffusWAKettingerLStephensTMissed opportunities for earlier diagnosis of HIV infection – South Carolina, 1997–2005MMWR Morb Mortal Wkly Rep200655471269127217136020
- DuffusWAWeisKKettingerLStephensTAlbrechtHGibsonJJRisk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individualsAIDS Patient Care STDS200923533934519320598
- World Health OrganizationWHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and childrenWHO2007 Available from: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdfAccessed November 16, 2015
- TaylorTNWeedonJGolubETLongitudinal trends in sexual behaviors with advancing age and menopause among women with and without HIV-1 infectionAIDS Behav201519593194025245474
- LindauSTSchummLPLaumannEOLevinsonWO’MuircheartaighCAWaiteLJA study of sexuality and health among older adults in the United StatesN Engl J Med2007357876277417715410
- WaiteLJLaumannEODasASchummLPSexuality: measures of partnerships, practices, attitudes, and problems in the national social life, health and aging studyJ Gerontol B Psychol Sci Soc Sci200964Suppl 1i56i6619497930
- LaumannEOGagnonJHMichaelRTThe social organization of sexuality: sexual practices in the United StatesChicagoThe University of Chicago Press1994
- DunnMECutlerNSexual issues in older adultsAIDS Patient Care STDS2000142669
- RosenRGTaylorJFGLeiblumSRBachmannGAPrevalence of sexual dysfunction in women: results of a survey study of 329 patients in an outpatient gynecological clinicJ Sex Marital Ther19941931711888246273
- BachmannGAInfluence of menopause on sexualityInt J Fertil Menopausal Stud199540Suppl 116227581585
- DiazTSchableBChuSYRelationship between use of condoms and other forms of contraception among human immunodeficiency virus-infected women. Supplement to HIV and AIDS Surveillance Project GroupObstet Gynecol19958622772827617361
- WilsonTEKoenigLJWalterEDual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIV-uninfected women: the importance of an event-level focus for promoting safer sexual behaviorsSex Transm Dis2003301180981214603086
- SchickVHerbenickDReeceMSexual behaviors, condom use, and sexual health of Americans over 50: implications for sexual health promotion for older adultsJ Sex Med20107Suppl 531532921029388
- SchableBChuSYDiazTCharacteristics of women 50 years of age or older with heterosexually acquired AIDSAm J Public Health19968611161616188916530
- AdekeyeOAHeimanHJOnyeaborOSHyacinthHIThe new invincibles: HIV screening among older adults in the U.SPLoS One201278e4361822952722
- WigfallLTRichterDLTorresMEHIV testing among midlife women in the deep south: an analysis of the 2008 behavioral risk factor surveillance system survey dataJ Women’s Health (Larchmt)201120693394121671778
- SkiestDJKeiserPHuman immunodeficiency virus infection in patients older than 50 years. A survey of primary care physicians’ beliefs, practices and knowledgeArch Fam Med1997632892949161358
- AkersAYBernsteinLDoyleJCorbie-SmithGOlder women and HIV testing: examining the relationship between HIV testing history, age, and lifetime HIV risk behaviorsSex Transm Dis200835442042318362866
- BachmannGALeiblumSRThe impact of hormones on menopasual sexuality: a literature reviewMenopause200411112012314716193
- SenanyakePWomen and reproductive health in a graying worldInt J Gynecol Obstet20007015967
- GolubSATomassilliJCPantaloneDWBrennanMKarpiakSEParsonsJTPrevalence and correlates of sexual behavior and risk management among HIV-positive adults over 50Sex Transm Dis2010371061562021305717
- MassadLSEvansCTWilsonTEImpact of menopause on condom use by HIV-seropositive and comparison seronegative womenJ Acquir Immune Defic Syndr200847340140218398976
- PsarosCBarinasJRobbinsGKBedoyaCASafrenSAParkERIntimacy and sexual decision making: exploring the perspective of HIV positive women over 50AIDS Patient Care STDS2012261275576023199193
- EmletCA“You’re awfully old to have this disease”: experiences of stigma and ageism in adults 50 years and older living with HIV/AIDSGerontologist200646678179017169933
- MassadLSEvansCEWilsonTEContraceptive use among U.S. women with HIVJ Women’s Health (Larchmt)200716565766617627401
- World Health OrganizationWorld Health Organization brief on anti-retroviral treatment (ART) in HIV and TB preventionWHO2011 Available from: http://www.princeton.edu/cbli/student-projects-1/WHO-brief-on-ART-and-Community-Viral-Load-jan_2011.pdfAccessed November 16, 2015
- AttiaSEggerMMullerMZwahlenMLowNSexual transmission of HIV according to viral load and antiretroviral therapy: a systematic review and meta-analysisAIDS200923111397140419381076
- RollenhagenCAsinSNEnhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responsesMucosal Immunol20114667168121881573
- MeloKCMeloMRRicciBVSeguradoACCorrelates of human immunodeficiency virus cervicovaginal shedding among postmenopausal and fertile-aged womenMenopause201219215015621983010
- ValdiglesiasVSanchez-FloresMMasedaALymphocyte subsets in a population of nonfrail elderly individualsJ Toxicol Environ Health A20157813–1479080426167746
- BalestreEEholieSPLokossueAEffect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West AfricaAIDS201226895195722382142
- GrabarSKousignianISobelAImmunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIVAIDS200418152029203815577624
- ManfrediRChiodoFA case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced ageAIDS200014101475147710930176
- Van BenthemBHVernazzaPCoutinhoRAPrinsMEuropean Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort Study. The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. For the European Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort StudyAIDS200216691992411919494
- PattersonKBCohnSEUyanikJHughesMSmurzynskiMEronJJTreatment responses in antiretroviral treatment (ART) naïve pre- and post-menopausal HIV-infected women: an analysis from ACTG studiesClin Infect Dis200949347347619555288
- CalvetGAVelasqueLLuzPMAbsence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, BrazilPLoS One201492e8929924586673
- DumondJBAdamsJLPrinceHMPharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot studyHIV Med201314740140923433482
- GervasoniCMeravigliaPLandonioSTenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected womenJ Antimicrob Chemother20136851206120723299572
- CottrellMLPattersonKBPrinceHMEffect of HIV-infection and menopause status on raltegravir pharmacokinetics in the blood and genital tractAntivir Ther Epub201563
- BaxiSMGreenblattRMBacchettiPCommon clinical conditions – age, low BMI, ritonavir use, mild renal impairment – affect tenofovir pharmacokinetics in a large cohort of HIV-infected womenAIDS2014281596624275255
- OrlandoGMeravigliaPCordierLAntiretroviral treatment and age-related comorbidities in a cohort of older, HIV-infected patientsHIV Med20067854955717105515
- de PommerolMHessamferMLawson-AyayiSMenopause and HIV infection: age at onset and associated factorsInt J STD AIDS2011222677221427426
- CooperGSSandlerDPAge at natural menopause and mortalityAnn Epidemiol1998842292359590601
- JacobsenBKHeuchIKvaleGAge at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian womenAm J Epidemiol20031571092392912746245
- GradyDSawayaGFDiscontinuation of postmenopausal hormone therapyAm J Med2005118Suppl 12B16316516414343
- SoaresCNPractical strategies for diagnosing and treating depression in women: menopausal transitionJ Clin Psychiatry20086910e3019192433
- SantoroNFanMMaslowBSchoenbaumEWomen and HIV infection: the makings of a midlife crisisMaturitas200964316016419783389
- FerreiraCEPinto-NetoAMMarques CondeDCosta-PaivaLMoraisSSMagalhaesJMenopause symptoms in women infected with HIV: prevalence and associated factorsGynecol Endocrinol200723419820517505939
- SchoenbaumEEHartelDLoYHIV infection, drug use, and onset of natural menopauseClin Infect Dis200541101517152416231267
- BoonyanurakPBunupuradahTWilawanKAge at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai womenMenopause201219782082422549170
- ImaiKSuttonMYMdodoRdel RioCHIV and menopause: a systematic review of the effects of HIV infection on age at menopause and the effects of menopause on response to antiretroviral therapyObstet Gynecol Int2013201334030924454386
- ClarkRACohnSEJarekCPerimenopausal symptomatology among HIV-infected women at least 40 years of ageJ Acquir Immune Defic Syndr20002319910010708064
- CejtinHEKalinowskiABacchettiPEffects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunctionObstet Gynecol200610861423143117138776
- RozenbaumHMenopause et regles en 2001. Resultats de l’enquete CLIMATSReprod Hum Hormones2002151122 French
- CejtinSHTaylorRWattsDHAssessment of menopausal status among women in the Women’s Interagency HIV Study (WIHS)Proceedings of the 57th International AIDS ConferenceJuly 11–16 2004Bangkok, Thailand
- GoldEBBrombergerJCrawfordSFactors associated with age at natural menopause in a multiethnic sample of midlife womenAm J Epidemiol2001153986587411323317
- BrombergerJTMatthewsKAKullerLHWingRRMeilahnENPlatingaPProspective study of the determinants of age at menopauseAm J Epidemiol199714521241339006309
- MacMahonBWorcesterJAge at menopause. United States – 1960–1962Vital Health Stat 111966191205298639
- ClarkRAMulliganKStamenovicEFrequency of anovulation and early menopause among women enrolled in selected AIDS clinical trials group studiesJ Infect Dis2001184101325132711679923
- ShahPNSmithJRWellsCMenstrual symptoms in women infected by the human immunodeficiency virusObstet Gyencol1994833397400
- HarlowSDSchumanPCohenMEffect of HIV infection on menstrual cycle lengthJ Acquir Immune Defic Syndr2000241687510877498
- MillerSASantoroNLoYMenopause symptoms in HIV-infected and drug-using womenMenopause200512334835615879925
- EnriquezMLackeyNWittJHealth concerns of mature women living with HIV in the Midwestern United StatesJ Assoc Nurses AIDS Care2008191374618191767
- TuchmanEMenopause symptom attribution among midlife women in methadone treatmentSoc Work Health Care2010491536720077319
- LoobySEShifrenJCorlessIIncreased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected womenMenopause201421440340923820600
- JohnsonTMCohenHWSantoroNAttribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using womenMenopause200815355155718188138
- RubinLHSundermannEECookJAInvestigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected womenMenopause2014219997100624496085
- TuchmanEPenningtonLEKullRMDaneshyarSRelationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot studySubst Use Misuse201348971171823607674
- TuchmanEExploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatmentSoc Work Health Care2007454436217954448
- MakiPMRubinLHCohenMDepressive symptoms are increased in the early perimenopausal stage in ethnically diverse HIV+ and HIV-womenMenopause201219111215122322872013
- MorrisonMFPetittoJMTen HaveTDepressive and anxiety disorders in women with HIV infectionAm J Psychiatry2002159578979611986133
- AtkinsonJHGrantINatural history of neuropsychiatric manifestations of HIV diseasePsychiatr Clin North Am199417117338190664
- LyketsosCGHooverDRGuccioneMChanges in depressive symptoms as AIDS develops. The multi-center AIDS cohort studyAm J Psychiatry199615311143014378890676
- MooreJSchumanPSchoenbaumEBolandBSolomonLSmithDSevere adverse life events and depressive symptoms among women, or at risk for, HIV infection in four cities in the United States of AmericaAIDS199913172459246810597788
- SorliniMLFocaEMottaDElderly women with human immunodeficiency virus infection: is there an effect of the virus on neuropsychological profile?J Am Geriatr Soc201462119419625180386
- BrombergerJTAssmannSFAvisNESchockenMKravitzHMCordalAPersistent mood symptoms in a multi-ethnic community cohort of pre- and perimenopausal womenAm J Epidemiol2003158434735612915500
- BrombergerJTMatthewsKASchottLLDepressive symptoms during the menopausal transition: the Study of Women’s Health Across the Nation (SWAN)J Affect Disord20071031–326727217331589
- BrombergerJTKravitzHJChangYFCyranowskiJMBrownCMatthewsKAMajor depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN)Psychol Med20114191879188821306662
- MohyiDTabassiKSimonJDifferential diagnosis of hot flashesMaturitas19972732032149288692
- HartelDLoYBauerCAttitudes toward menopause in HIV-infected and at-risk womenClin Interv Aging20083356156618982926
- CookJACohenMHBurkeJEffects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive womenJ Acquir Immune Defic Syndr200230440140912138346
- CookJAGreyDBurkeJDepressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive womenAm J Public Health20049471133114015226133
- TedaldiEMMinnitiNLFischerTHIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesBiomed Res Int2015201564191325815329
- Marques CondeDSilvaETAmaralWNHIV, reproductive aging, and health implications in women: a literature reviewMenopause200916119921318800017
- RichardsonJLMartinEMJimenezNNeuropsychological functioning in a cohort of HIV infected women: importance of anti-retroviral therapyJ Int Neuropsychol Soc20028678179312240742
- FreemanEWSammelMDLinHNelsonDBAssociations of hormones and menopausal status with depressed mood in women with no history of depressionArch Gen Psychiatry200663437538216585466
- LindsayRHartDMAitkenJMMacDonaldEBAndersonJBClarkeACLong-term prevention of postmenopausal osteoporosis by oestrogen: evidence for increased bone mass after delayed onset of oestrogen treatmentLancet1976179681038104057448
- GomesDCValadaresALde MoraesMJLagruttaBBPinto-NetoAMCosta-PaivaLLow bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factorsMenopause201422222423025003619
- AbergJAGallantJEGhanemKGEmmanuelPZingmanBSHorbergMInfectious Diseases Society of AmericaPrimary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of AmericaClin Infect Dis201458111024343580
- HoyJBone disease in HIV: recommendations for screening and management in the older patientDrugs Aging201532754955826123948
- PapaioannouAMorinSCheungA2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summaryCMAJ2010182171864187320940232
- World Health OrganizationWHO Scientific Group on the assessment of osteoporosis as the primary care levelGeneva, SwitzerlandWorld Health Organization2004 Available from: http://www.who.int/chp/topics/Osteoporosis.pdfAccessed November 16, 2015
- World Health OrganizationAdherence to long-term therapies: evidence for actionGeneva, SwitzerlandWorld Health Organization2003 Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdfAccessed November 16, 2015
- National Institutes of HealthOsteoporosis prevention, diagnosis and therapyNIH Consensus Statement200017145
- CotterAGSabinCASimelaneSRelative contribution of HIV infection, demographics and body mass index to bone mineral densityAIDS201428142051206025265073
- DolanSEKanterJRGrinspoonSLongitudinal analysis of bone density in human immunodeficiency virus-infected womenJ Clin Endocrinol Metab20069182938294516735489
- BrownTTQaqishRBAntiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic reviewAIDS200620172165217417086056
- Walker HarrisVBrownTTBone loss in HIV-infected patients: evidence, clinical implications, and treatment strategiesJ Infect Dis2012205Suppl 3S391S39822577213
- BrownTTHoyJBorderiMRecommendations for evaluation and management of bone disease in HIVClin Infect Dis20156081242125125609682
- YinMTMcMahonDJFerrisDCLow bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected womenJ Clin Endocrinol Metab201095262062919965927
- ArnstenJHFreemanRHowardAAFloris-MooreMSantoroNSchoenbaumEEHIV infection and bone mineral density in middle-aged womenClin Infect Dis20064271014102016511769
- McComseyGATebasPShaneEBone disease in HIV infection: a practical review and recommendations for HIV care providersClin Infect Dis201051893794620839968
- CortesYIYinMTReameNKBone density and fractures in HIV-infected postmenopausal women: a systematic reviewJ Assoc Nurses AIDS Care201526438739826066693
- BonjochAFiguerasMEstanyCHigh prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort studyAIDS201024182827283321045635
- McComseyGAKitchDDaarESBone mineral density and fractures in antiretroviral-naïve persons randomized to receive abacavir-lamivudine or tenofovir-disoproxil-fumarate-emtricitabine along with efavirenz or atazanvir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202J Infect Dis2011203121791180121606537
- BollandMJWangTKGreyAGambleGDReidIRStable bone density in HAART-treated individuals with HIV: a meta-analysisJ Clin Endocrinol Metab20119692721273121715534
- BrownTTMcComseyGAKingMSQaqishRBBernsteinBMda SilvaBALoss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimenJ Acquir Immune Defic Syndr200951555456119512937
- YinMTModarresiRShaneEEffects of HIV infection and anti-retroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal womenOsteoporos Int20112251459146820683705
- Pinto-NetoLFRagi-EisSVieiraNFLow bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian populationJ Clin Densitom201114443443922051092
- ArnstenJHFreemanRHowardAAFloris-MooreMLoYKleinRSDecreased bone mineral density in aging men with or at risk for HIV infectionAIDS200721561762317314524
- SteinEMYinMTMcMahonDJVitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American womenOsteporos Int2011222477487
- YinMTDobkinJBrudneyKBone mass and mineral metabolism in HIV+ postmenopausal womenOsteoporos Int200516111345135215754081
- SharmaACohenHWFreemanRSantoroNSchoenbaumEEProspective evaluation of bone mineral density among middle-aged HIV-infected and unifected women: association between methadone use and bone lossMaturitas201170329530121944566
- PriorJBurdgeDMaanEFragility fractures and bone mineral density in HIV-positive women: a case-control population-based studyOsteporos Int2007181013451353
- DravidAKulkarniMBorkarADhandeSPrevalence of low bone mineral density among HIV patients on long-term suppressive antiretroviral therapy in resource-limited setting of western IndiaJ Int AIDS Soc2014174 Suppl 31956725394074
- SharmaAFlomPLRosenCJSchoenbaumEERacial differences in bone loss and relation to menopause among HIV-infected and uninfected womenBone201577243025896953
- YinMTShiQHooverDRFracture incidence in HIV-infected women: results from the Women’s Interagency HIV StudyAIDS201024172679268620859192
- RodriguezMDanielsBGunawardeneSRobbinsGKHigh frequency of vitamin D deficiency in ambulatory HIV-positive patientsAIDS Res Hum Retroviruses200925191419108690
- DobsASDempseyMALadensonPWPolkBFEndocrine disorders in men infected with human immunodeficiency virusAm J Med1988843 Pt 26116163348269
- HaugCJAukrustPHaugEMorkridLMullerFFrolandSSSevere deficiency of 1,25-dihdyroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasisJ Clin Endocrinol Metab19988311383238389814454
- HuangJSWilkieSJSullivanMPGrinspoonSReduced bone density in androgen-deficient women with acquired immune deficiency syndrome wastingJ Clin Endocrinol Metab20018683533353911502775
- BollandMJGreyABGambleGDReidIRLow body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysisJ Clin Endocrinol Metab200792124522452817925333
- AnastosKLuDShiOThe association of bone mineral density with HIV infection and antiretroviral treatment in womenAntivir Ther20071271049105818018763
- CaputoBVTraversa-CaputoGCCostaCGiovaniEMEvaluation of bone alterations in the jaws of HIV-infected menopausal womenBraz Oral Res201327323123723657485
- YinMTShuAZhangCATrabecular and cortical microarchitecture in postmenopausal HIV-infected womenCalcif Tissue Int201392655756523460340
- ShiauSBrounECArpadiSMYinMTIncident fractures in HIV-infected individuals: a systematic review and meta-analysisAIDS201327121949195724126140
- WomackJAGouletJLGibertCIncreased risk of fragility fractures among HIV infected compared to uninfected male veteransPLoS One201162e1721721359191
- TriantVABrownTTLeeHGrinspoonSKFracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare systemJ Clin Endocrinol Metab20089393499350418593764
- DaoCYoungBBuchaczKHigher and increasing rates of fracture among HIV-infected persons in the HIV-Outpatient Study (HOPS) compared to the general US population, 1994 to 2008 [abstract 128]Program and abstracts of the 17th Conference on Retroviruses and Opportunistic InfectionsFebruary 18, 2010San Francisco, California
- CollinFDuvalXLe MoingVTen-year incidence and risk factors of bone fractures in a cohort of treated HIV-1 infected adultsAIDS20092381021102419300202
- Guerri-FernandezRVestergaardPCarbonellCHIV infection is strongly associated with hip fracture risk, independent of age, gender, and comorbidities: a population-based cohort studyJ Bone Miner Res20132861259126323362011
- GrantPMKitchDMcComseyGALow baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationClin Infect Dis201357101483148823943825
- CarrAGrundBNeuhausJPrevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of Antiretroviral Treatment (START) trialHIV Med201516Suppl 113714625711332
- CassettiIMadrugaJVSuleimanJMThe safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1 infected patientsHIV Clin Trials20078316417217621463
- DuvivierCKoltaSAssoumouLGreater decrease in bone mineral density with protease inhibitor regimens compared with non-nucleoside reverse transcriptase inhibitor regimens in HIV-1-infected naïve patientsAIDS200923781782419363330
- GallantJEStaszewskiSPozniakALEfficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral-naïve patients: a 3 year randomized trialJAMA2004292219120115249568
- PanGWuXMcKennaMAFengXNagyTRMcDonaldJMAZT enhances osteoclastogenesis and bone lossAIDS Res Hum Retroviruses200420660862015242537
- FuxCARauchASimcockMTenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort StudyAntivir Ther20081381077108219195333
- StellbrinkHJOrkinCArribasJRComparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT studyClin Infect Dis201051896397220828304
- MallonPWHIV and bone mineral densityCurr Opin Infect Dis20102311820010102
- TsekesGChrysosGDouskasGBody composition changes in protease inhibitor-naïve HIV-infected patients treated with two nucleoside reverse transcriptase inhibitorsHIV Med200232859012010354
- TebasPPowderlyWBClaxtonSAccelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapyAIDS2000144F63F6710770534
- Fernandez-RiveraJGarciaRLozanoFRelationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patientsHIV Clin Trials20034533734614583850
- MondyKYarasheskiKPowderlyWGLongitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individualsClin Infect Dis200336448249012567307
- JonesSRestrepoDKasowitzARisk factors for decreased bone density and effects of HIV on bone in the elderlyOsteporos Int2008197913918
- BlochMTongWWHoyJSwitch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover 48 weeksHIV Med201415637338024460797
- CotterAGMallonPWThe effects of untreated and treated HIV infection on bone diseaseCurr Opin HIV AIDS201491172624263798
- AsboeDAitkenCBoffitoBritish HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals, 2011HIV Med201213114422171742
- European AIDS Clinical SocietyEACS Guidelines Version 7.1EACS2014 Available from: http://www.eacsociety.org/files/guidelines-7.1-english.pdfAccessed November 16, 2015
- World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UKFRAX – WHO Fracture Risk Assessment Tool Available from: https://www.shef.ac.uk/FRAX/tool.jspAccessed November 16, 2015
- WattsNBBilezikianJPCamachoPMAmerican Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosisEndocrine Practice201016Suppl 313621224201
- AllavenaCDelpierreCCuzinLHigh frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugsJ Antimicrob Chemother20126792222223022589455
- MondyKPowderlyWGClaxtonSAAlendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infectionJ Acquir Immune Defic Syndr200538442643115764959
- RozenbergSLanoyEBentataMEffect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120)AIDS Res Hum Retroviruses201228997298022353022
- GuaraldiGOrlandoGMadedduGAlendronate reduces bone resorption in HIV-associated osteopenia/osteoporosisHIV Clin Trials20045526927715562367
- McComseyGAKendallMATebasPAlendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIVAIDS200721182473248218025884
- BollandMJGreyABHorneAMAnnual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trialJ Clin Endocrinol Metab20079241283128817227801
- HuangJMeixnerLFernandezSMcCutchanJAA double-blind, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosisAIDS2009231515719050386